Skip to main content
Clinical Trials/RBR-6prps8g
RBR-6prps8g
Not yet recruiting
Phase 2

HOTFy: randomised clinical trial to Hyperbaric Oxygen Therapy in Fibromyalgia

niversidade Federal de Juiz de Fora0 sitesJune 17, 2022
ConditionsFibromyalgia

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
niversidade Federal de Juiz de Fora
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 17, 2022
End Date
December 1, 2023
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de Juiz de Fora

Eligibility Criteria

Inclusion Criteria

  • ages between 18\-70 years; diagnosis of fibromyalgia at least 2 years prior to enrollment based on one of two criteria: symptoms of generalized pain occurring above and below the waist and affecting the right and left sides of the body for at least 3 months and not having another somatic disorder that warrants the symptoms and/or presence of at least 11 of the 18 tender points (Tender Points”).

Exclusion Criteria

  • contraindications for hyperbaric oxygen therapy (pregnancy, use of bleomycin, cisplatin, disulfiram and doxorubicin, middle ear surgery, untreated pneumothorax or pneumomediastinum, claustrophobia); associated autoimmune rheumatologic disease and inability to sign the informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials